APOLLO HOSPITALS ENTERPRISE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,057 INR | +0.70% |
|
+3.72% | +6.18% |
| May. 31 | Transcript : Apollo Hospitals Enterprise Limited, Q4 2024 Earnings Call, May 31, 2024 | |
| May. 31 | Apollo Hospitals Enterprise Posts Gains in Fiscal Q4 Consolidated Net Profit | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 92.36 and 58.59 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 4.71 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +6.18% | 10.36B | B+ | ||
| -25.47% | 15.13B | B+ | ||
| -3.60% | 11.77B | B | ||
| +28.62% | 8.54B | B | ||
| -6.29% | 7.42B | A- | ||
| +5.50% | 6.72B | B- | ||
| +8.59% | 6.32B | D | ||
| -2.79% | 4.3B | - | ||
| +9.97% | 4.21B | B+ | ||
| +26.42% | 3.95B | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- APOLLOHOSP Stock
- Ratings Apollo Hospitals Enterprise Limited
